Cargando…
Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease
BACKGROUND: The proteases (secretases) that cleave amyloid-β (Aβ) peptide from the amyloid precursor protein (APP) have been the focus of considerable investigation in the development of treatments for Alzheimer disease. The prediction has been that reducing Aβ production in the brain, even after th...
Autores principales: | Jankowsky, Joanna L, Slunt, Hilda H, Gonzales, Victoria, Savonenko, Alena V, Wen, Jason C, Jenkins, Nancy A, Copeland, Neal G, Younkin, Linda H, Lester, Henry A, Younkin, Steven G, Borchelt, David R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1283364/ https://www.ncbi.nlm.nih.gov/pubmed/16279840 http://dx.doi.org/10.1371/journal.pmed.0020355 |
Ejemplares similares
-
Expression of stabilized β-catenin in differentiated neurons of transgenic mice does not result in tumor formation
por: Kratz, John E, et al.
Publicado: (2002) -
Remodeling Alzheimer-amyloidosis models by seeding
por: Ulm, Brittany S., et al.
Publicado: (2021) -
Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease
por: Simmons, Christopher R, et al.
Publicado: (2011) -
Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult
por: Rodgers, Shaefali P, et al.
Publicado: (2012) -
Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk
por: Simmons, Christopher R, et al.
Publicado: (2011)